Role of Bioinformatics in Cancer Diagnostic Advancements
X.D. Wang, L. Liotta L. Clinical bioinformatics: a new emerging science, J Clin Bioinform. 2011; 1(1): 1p. 10.1186/2043-9113-1-1.
M.E. Holford, J.P. McCusker, K.H. Cheung, M. Krauthammer. A semantic web framework to integrate cancer omics data with biological knowledge, BMC Bioinform. 2012; 13(Suppl 1): S10p. 10.1186/1471-2105-13-S10-S10.
M.T.W. Ebbert, R.R.L. Bastien, K.M. Boucher, M. Martín, E. Carrasco, R. Caballero, I.J. Stijleman, P.S. Bernard, J.C. Facelli. Characterization of uncertainty in the classification of multivariate assays: application to PAM50 centroid-based genomic predictors for breast cancer treatment plans, J Clin Bioinforma. 2011; 1: 37p. 10.1186/2043-9113-1-37.
C. Laczny, P. Leidinger, J. Haas, N. Ludwig, C. Backes, A. Gerasch, M. Kaufmann, B. Vogel, H.A. Katus, B. Meder, et al. miRTrail – a comprehensive webserver for analyzing gene and miRNA patterns to enhance the understanding of regulatory mechanisms in diseases, BMC Bioinform. 2012; 13(1): 36p. 10.1186/1471-2105-13-36.
Y. Kimori. Mathematical morphology-based approach to the enhancement of morphological features in medical images. J Clin Bioinforma. 2011; 1: 33p. 10.1186/2043-9113-1-33.
V. Haustein, U. Schumacher. A dynamic model for tumour growth and metastasis formation, J Clin Bioinforma. 2012.
S. von der Heyde, T. Beissbarth. A new analysis approach of epidermal growth factor receptor pathway activation patterns provides insights into cetuximab resistance mechanisms in head and neck cancer, BMC Med. 2012.
X.D. Wang. Role of clinical bioinformatics in the development of network-based biomarkers, J Clin Bioinforma. 2011; 1: 28p. 10.1186/2043-9113-1-28.
D.J. Wu, D. Zhu, M. Xu, R.M. Rong, Q.Y. Tang, X.D. Wang, T.Y. Zhu. Analysis of transcriptional factors and regulation networks in patients with acute renal allograft rejection, J Proteome Res. 2011; 10(1): 175–81p. 10.1021/pr100473w.
H. Chen, Z.J. Song, M.J. Qian, C.X. Bai, X.D. Wang. Selection of disease-specific biomarkers by integrating inflammatory mediators with clinical informatics in AECOPD patients: a preliminary study, J Cell Mol Med. 2011; Aug 25. doi: 10.1111/j.1582–4934.2011.01416.x.
Y. Cun, H. Fröhlich. Prognostic gene signatures for patient stratification in breast cancer – accuracy, stability and interpretability of gene selection approaches using prior knowledge on protein-protein interactions, BMC Bioinform. 2012. (MS: 1321151249583179 in pre-accept).
H. Chen, Y. Wang, C. Bai, X.D. Wang. Alterations of plasma inflammatory biomarkers in the healthy and chronic obstructive pulmonary disease patients with or without acute exacerbation, J Proteomics. 2012, 10p.
L. Hood, S.H. Predictive, personalized, preventive, participatory (P4) cancer medicine, Nat Rev Clin Oncol. 2011; 8: 184–7p. 10.1038/nrclinonc.2010.227.
L. Hood, J.R. Heath, M.E. Phelps, B. Lin. Systems biology and new technologies enable predictive and preventative medicine, Science. 2004; 306(5696): 640–3p. 10.1126/science.1104635.
Q. Tian, N.D. Price, L. Hood. Systems cancer medicine: towards realization of predictive, preventive, personalized and participatory (P4) medicine, J Intern Med. 2012; 271(2): 111–21p. 10.1111/j.1365-2796.2011.02498.x.
X. Ren, Y. Wang, J. Wang, X.S. Zhang. A unified computational model for revealing and predicting subtle subtypes of cancers, BMC Bioinform. 2012.
A. González-Beltrán, B. Tagger, A. Finkelstein. Federated ontology-based queries over cancer data, BMC Bioinform. 2012; 13(Suppl 1): S9p. 10.1186/1471-2105-13-S11-S9.
E.T. Sawey, M. Chanrion, C. Cai, G. Wu, J. Zhang, L. Zender, A. Zhao, R.W. Busuttil, H. Yee, L. Stein, et al. Identification of a therapeutic strategy targeting amplified FGF19 in liver cancer by oncogenomic screening, Cancer Cell. 2011; 19(3): 347–58p. 10.1016/j.ccr.2011.01.040.
S. Nagl (ed). Cancer Bioinformatics; From Therapy Design to Treatment. Vol. 30, Publisher: John Wiley & Sons; 2006, 287p.
- There are currently no refbacks.